- Home
- Study Design
-
- Primary Endpoint
- ARR
- Secondary Endpoints
- Patients Without Relapse
- GdE | T2
- Disability Progression
- Whole Brain Volume Loss
- Exploratory Endpoints
- Cortical Grey Volume Loss
- Thalamic Volume Loss
- Post Hoc Analysis
- Cognitive Processing Speed
- Safety
- Adverse Reactions
- Discontinuation Rates
- Serious Infections and Malignancies
- ALC Profile
- Primary Endpoint